CATHERINE GLASGOW: Open Payments
NPI 1205228012 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 62 payments from 24 companies in 2025. Trend: 2023 $936 · 2024 $1,112 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 7 | $232 |
| Novo Nordisk Inc | 13 | $217 |
| ABBVIE INC. | 4 | $88 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Viatris Specialty LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| SHIELD THERAPEUTICS INC | 3 | $51 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $43 |
Products named: RECORLEV, Ozempic, REXULTI, Wegovy, Auvelity, YUPELRI, JARDIANCE, ACCRUFER.
Industry payments across CA — which companies pay providers there.
